Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt
- PMID: 15940546
- DOI: 10.1007/s00467-005-1900-2
Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt
Abstract
To highlight the characteristics of Egyptian children with systemic lupus erythematosus (SLE), the records of 52 SLE patients (48 girls and four boys aged 11.9+/-2.6 years) were retrospectively analyzed. The median duration of follow up was 22 months (range 1-94.5). The most common extrarenal manifestation was fever (76.6%), followed by joint involvement (65.4%). Hemolytic anemia was demonstrated in 51%, thrombocytopenia in 29.2%, and leucopenia in 27.5%. Antinuclear antibodies were positive in 92.7%, while positive anti-double-stranded DNA and hypocomplementemia were demonstrated in 95.6% and 67.4%, respectively. Lupus nephritis (LN) was evident in 80.8%. The renal manifestations of LN patients were proteinuria (83.3%), hematuria (71.5%), hypertension (35.7%), and elevated serum creatinine (16.7%). The histopathological findings of the initial renal biopsies were class I (4.9%), class II (22%), class III (36.3%), and class IV (36.3%). Among patients without LN, 85.7% gained remission and nonimmediately died. At last observation, 55.6% of LN patients had complete remission, 22.2% had active disease, and 22.2% died. Most patients who died had class IV LN. In conclusion, the characteristics of Egyptian SLE children are comparable with those in most Arab and Western series. However, LN may be more prevalent and severe, with unfavorable outcomes.
Similar articles
-
Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.Lupus. 2017 Dec;26(14):1564-1570. doi: 10.1177/0961203317716320. Epub 2017 Jun 17. Lupus. 2017. PMID: 28625079
-
Lupus nephritis in childhood: a review of 53 patients followed at a single center.Pediatr Nephrol. 2004 Jan;19(1):36-44. doi: 10.1007/s00467-003-1278-y. Epub 2003 Nov 22. Pediatr Nephrol. 2004. PMID: 14634858
-
Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.Lupus. 2016 Apr;25(5):547-57. doi: 10.1177/0961203315619031. Epub 2015 Dec 3. Lupus. 2016. PMID: 26637291
-
Lupus nephritis in children.Indian J Pediatr. 1999 Mar-Apr;66(2):215-23. doi: 10.1007/BF02761212. Indian J Pediatr. 1999. PMID: 10798064 Review.
-
International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis.Arthritis Rheumatol. 2022 Feb;74(2):263-273. doi: 10.1002/art.41930. Epub 2022 Jan 4. Arthritis Rheumatol. 2022. PMID: 34279063 Free PMC article.
Cited by
-
Clinical and laboratory variables of childhood systemic lupus erythematosus in western province of Saudi Arabia.Rheumatol Int. 2011 Jan;31(1):23-6. doi: 10.1007/s00296-009-1210-2. Epub 2009 Nov 7. Rheumatol Int. 2011. PMID: 19898847
-
Lupus nephritis in Egyptian children: a 16-year experience.J Nephrol. 2015 Oct;28(5):557-62. doi: 10.1007/s40620-014-0157-x. Epub 2014 Dec 10. J Nephrol. 2015. PMID: 25491938
-
Juvenile systemic lupus erythematosus onset patterns in Vietnamese children: a descriptive study of 45 children.Pediatr Rheumatol Online J. 2012 Nov 19;10(1):38. doi: 10.1186/1546-0096-10-38. Pediatr Rheumatol Online J. 2012. PMID: 23164451 Free PMC article.
-
Urinary Neutrophil Gelatinase-Associated Lipocalin and Urinary Soluble CXCL16 as Biomarkers of Activity in Pediatric Lupus Nephritis.Indian J Nephrol. 2018 Nov-Dec;28(6):427-432. doi: 10.4103/ijn.IJN_265_17. Indian J Nephrol. 2018. Retraction in: Indian J Nephrol. 2023 Nov-Dec;33(6):492. doi: 10.4103/0971-4065.282823. PMID: 30647496 Free PMC article. Retracted.
-
End-stage renal disease as the presenting manifestation of renal systemic lupus erythematosus.Pediatr Nephrol. 2007 Jan;22(1):149-51. doi: 10.1007/s00467-006-0297-x. Epub 2006 Sep 15. Pediatr Nephrol. 2007. PMID: 16977472
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical